NCT01777646View on ClinicalTrials.gov

Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2015

Conditions
Amyotrophic Lateral Sclerosis
Interventions
BIOLOGICAL

MSC_NTF cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the CSF

Trial Locations (1)

91120

Hadassah Medical Organization, Jerusalem

Sponsors
All Listed Sponsors
collaborator

Hadassah Medical Organization

OTHER

lead

Brainstorm-Cell Therapeutics

INDUSTRY